114 related articles for article (PubMed ID: 22981938)
1. A patient with metastatic breast cancer 15 years after bilateral prophylactic total mastectomy and oophorectomy.
El-Amm J; Ghanem H; Zeck J; Akin E; Siegel R
Clin Breast Cancer; 2012 Dec; 12(6):450-3. PubMed ID: 22981938
[No Abstract] [Full Text] [Related]
2. [Bilateral carcinoma of the breast: treatment and prevention, Review of the literature].
Muratori L; Giacomelli L; Brescia A; Gentili G; Miglietta AM; Pulcini A; Granai AV; Messinetti S
Ann Ital Chir; 1993; 64(5):489-93; discussion 493-4. PubMed ID: 8010576
[TBL] [Abstract][Full Text] [Related]
3. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
4. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic oophorectomy in the treatment of carcinoma of the breast.
Tengrup I; Nittby LT; Landberg T
Surg Gynecol Obstet; 1986 Mar; 162(3):209-14. PubMed ID: 3513347
[TBL] [Abstract][Full Text] [Related]
7. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
[TBL] [Abstract][Full Text] [Related]
8. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
10. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic laparoscopic ovarian ablation for premenopausal breast cancer: medical and economic efficacy.
Kwon AH; Yamada O; Uetsuji S; Matsui Y; Kamiyama Y
Surg Laparosc Endosc; 1997 Jun; 7(3):223-7. PubMed ID: 9194283
[TBL] [Abstract][Full Text] [Related]
12. Current management of primary breast cancer. Part I: Screening, diagnosis, staging and local treatment of stage I and II disease.
Lopez MJ; Andriole DP
Mo Med; 1990 Sep; 87(9):684-90. PubMed ID: 2215472
[TBL] [Abstract][Full Text] [Related]
13. "Early" carcinoma of the breast: evaluation of regional therapy and features influencing prognosis.
Eilber FR; Milne CA; White EC; McBride CM
South Med J; 1982 Jan; 75(1):9-13. PubMed ID: 7054889
[TBL] [Abstract][Full Text] [Related]
14. [The multicentricity of minimal breast cancer. The observations and therapeutic implications apropos 30 cases].
Cervi GC; Giulini SM; Pouchè A; Coniglio A; Galvani G; Tambussi U; Floriani M; Tiberio G
Minerva Med; 1989 Aug; 80(8):895-9. PubMed ID: 2552356
[No Abstract] [Full Text] [Related]
15. [Breast cancer].
Ataseven B; Eiermann W
Dtsch Med Wochenschr; 2006 May; 131(19):1091-9; quiz 1101-2. PubMed ID: 16685631
[No Abstract] [Full Text] [Related]
16. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; van Geel B; van Putten WL; Henzen-Logmans SC; Seynaeve C; Menke-Pluymers MB; Bartels CC; Verhoog LC; van den Ouweland AM; Niermeijer MF; Brekelmans CT; Klijn JG
N Engl J Med; 2001 Jul; 345(3):159-64. PubMed ID: 11463009
[TBL] [Abstract][Full Text] [Related]
17. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
18. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
19. [Intraductal spread of carcinoma: a risk for breast conserving surgery].
Ohuchi N; Furuta A; Mori S
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():183-9. PubMed ID: 8037480
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic mastectomy of the contralateral breast.
Morrow M
Breast; 2011 Oct; 20 Suppl 3():S108-10. PubMed ID: 22015275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
